These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4278529)

  • 21. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biophysical mechanisms and kinetics of thrombocyte aggregation].
    Gavrilov VB; Khovratovich VI
    Tsitologiia; 1984 Dec; 26(12):1401-8. PubMed ID: 6528363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aggregation effectors and human platelet populations].
    Rendu F; Rodriguez-Zeballos A; Caen J
    Nouv Rev Fr Hematol; 1972; 12(5):708. PubMed ID: 4266446
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
    Akman N
    Haematologica; 1980 Aug; 65(4):546-51. PubMed ID: 6774930
    [No Abstract]   [Full Text] [Related]  

  • 25. "In vitro" and "in vivo" experiences with VK 774, a new platelet function inhibitor.
    ten Cate JW; Gerritsen J; van Geet-Weijers J
    Pathol Biol (Paris); 1972 Dec; ():Suppl:76-81. PubMed ID: 4574610
    [No Abstract]   [Full Text] [Related]  

  • 26. Independency of release reaction on aggregation in ADP stimulated-platelet.
    Kawarabayashi K; Hashimoto K; Tatsumi N
    Osaka City Med J; 1984 Dec; 30(2):125-37. PubMed ID: 6536911
    [No Abstract]   [Full Text] [Related]  

  • 27. The reversibility by dipyridamole of the increased sensitivity of in vivo platelet aggregation in rabbits after alloxan.
    Honour AJ; Hockaday TD; Mann JI
    Br J Exp Pathol; 1976 Feb; 57(1):11-5. PubMed ID: 1268037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flow.
    Goldsmith HL; Kaufer ES; McIntosh FA
    Biorheology; 1995; 32(5):537-52. PubMed ID: 8541523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients].
    Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP
    Ter Arkh; 1992; 64(8):39-43. PubMed ID: 1440393
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenine nucleotides as tools in platelet studies.
    Maguire MH
    Proc West Pharmacol Soc; 1981; 24():381-4. PubMed ID: 7255483
    [No Abstract]   [Full Text] [Related]  

  • 34. Human platelets 5'-nucleotidase: a cell membrane ectoenzyme with a possible regulatory role in the aggregation reaction.
    Bergamini C; Grazi E
    Ital J Biochem; 1980; 29(4):273-88. PubMed ID: 6260705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of platelet-suppressive agents.
    Wautier JL; Caen JP
    Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
    [No Abstract]   [Full Text] [Related]  

  • 36. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of human platelets to sheer stress.
    Brown CH; Lemuth RF; Hellums JD; Leverett LB; Alfrey CP
    Trans Am Soc Artif Intern Organs; 1975; 21():35-9. PubMed ID: 1146007
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.